SynthesisWorld journal of surgical oncology2025
Cardiopulmonary bypass versus non-bypass surgery for tumor thrombus extending into the inferior vena cava or right atrium in non-cardiac malignancies: a systematic review and meta-analysis.
Synthesis in World journal of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Extraction of atrial tumor thrombus in renal cell carcinoma via a complete transabdominal approach.Translational andrology and urology · 2026Article
- Modern management of locally advanced renal cancers with inferior vena cava thrombus.World journal of urology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe role of cardiopulmonary bypass (CPB) in surgery for tumor thrombi extending into the inferior vena cava (IVC) or right atrium in noncardiac malignancies remains controversial. We systematically compared perioperative mortality and complications between the CPB and non-CPB approaches and summarized findings on surgical techniques and patient selection.
methodsWe searched major databases for studies (2015-2025) reporting surgical resection of IVC or right atrial tumor thrombi in noncardiac malignancies stratified by CPB use. Twenty studies were included in the qualitative synthesis, and nine were included in the quantitative meta-analysis. Pooled perioperative mortality and complications were compared via random effects models. Heterogeneity and correlations between CPB use and mortality were assessed.
resultsSurgical approaches varied. CPB was typically reserved for extensive thrombus or right atrial involvement. The complication and recurrence rates were heterogeneous. In nine studies (800 patients), the pooled perioperative mortality rate was 9.2% (95% CI: 4.7-17.1%), with no significant difference between the CPB (10.3%) and non-CPB (7.8%) groups. High heterogeneity reflected differences in patient selection, tumor extent, and surgical technique. Qualitative synthesis indicated that CPB increased procedural complexity and risk but was utilized for more advanced disease. Recurrence and long-term outcomes have been inconsistently reported. Most studies were retrospective and at moderate to serious risk of bias.
conclusionSurgical management with or without CPB results in similar perioperative mortality rates. CPB is generally reserved for extensive thrombi, adding complexity and risk. Individualized, multidisciplinary planning is essential. Prospective studies are needed to refine patient selection and optimize surgical strategies in this challenging setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.